Virax Biolabs Group Limited Recorded Big Gain
Mon, Aug 01, 2022 at 06:47 PM
Virax Biolabs Group Limited (VRAX:NASDAQ) rocketted at $11.85, representing a gain of 119.4%. The stock got featured on our News Catalysts scanner on Tue, Jul 26, 2022 at 08:12 AM in the 'BIOTECH' category. From Thu, Jul 21, 2022, the stock recorded 71.43% Up Days and 62.50% Green Days
The stock spiked on Fri, Jul 29, 2022 at $29 with a volume of 8M+.
About Virax Biolabs Group Limited (VRAX:NASDAQ)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...
Top 10 Gainers:
- Virax Biolabs Group Limited (VRAX:NASDAQ), 119.44%
- Ontrak Inc. (OTRK:NASDAQ), 107.69%
- Revlon, Inc. (REV:NYSE), 89.93%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 85.38%
- Mediaco Holding Inc. (MDIA:NASDAQ), 60.87%
- Nanobiotix S.A. (NBTX:NASDAQ), 46.98%
- Celyad SA (CYAD:NASDAQ), 40.8%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 38%
- TherapeuticsMD, Inc. (TXMD:NASDAQ), 36.6%
- MAIA Biotechnology Inc. (MAIA:NYSEMKT), 34.48%